Impact of chronic statin-pretreatment on myocardial damage as assessed by Cardiac Magnetic Resonance findings in patients with acute ST-elevation myocardial infarction by Fuernau, Georg et al.
ORAL PRESENTATION Open Access
Impact of chronic statin-pretreatment on
myocardial damage as assessed by Cardiac
Magnetic Resonance findings in patients with
acute ST-elevation myocardial infarction
Georg Fuernau
*, Ingo Eitel, Steffen Desch, Suzanne de Waha, Gerhard Schuler, Holger Thiele
From 15th Annual SCMR Scientific Sessions
Orlando, FL, USA. 2-5 February 2012
Background
Recent data have demonstrated a lower mortality in
acute ST-elevation myocardial infarction (STEMI)
patients with previous treatment with statins, especially
in patients with high risk profiles. Moreover, a signifi-
cant reduction in enzymatic infarct size in non-STEMI
patients could be observed. However, systematic data of
the impact of chronic statin pre-treatment on myocar-
dial damage and reperfusion injury assessed with the
gold standard cardiac magnetic resonance imaging
(CMR) are lacking.
The aim of our prospective study was therefore to
assess the effects of a chronic statin pre-treatment on
myocardial damage as assessed by CMR in patients with
acute reperfused STEMI.
Methods
We enrolled 220 consecutive patients with acute STEMI
undergoing primary PCI within 12 hours of symptom
onset in our study. CMR studies were performed 2-4
days after the index eventinfarction (median 3 days,
interquartile range 2, 4 days) using a standard infarction
protocol.
Results
Of 220 patients, 35 (15.9 %) had chronic statin pre-
treatment. There was no difference in pain-to-balloon
time between the two groups (statin vs. no statins: 300.2
±178.2 vs. 288.7±179.8 min, p=0.73), but the statin
group showed a trend towards a higher TIMI risk-score
(4.5±2.0 vs. 3.7±2.3, p=0.054) and higher age (68.7±11.0
vs. 64.9±12.6 years, p=0.09). In cMRI no differences in
the area at risk (35.8±12.9 vs. 35.6±10.9 %LV, p=0.96)
and left ventricular ejection fraction (48.4±11.4 vs. 50.5
±12.0 %, p=0.35) could be observed. Infarct size showed
no statistical significant difference (18.0±11.5 vs. 15.3
±12.0 %LV, p=0.23) but statin pre-treatment resulted in
a significant higher myocardial salvage index as com-
pared to patients without statin pre-treatment (59.8
±27.4 vs. 49.1±27.0, p=0.04).
Conclusions
Statin pretreatment in patients with STEMI is associated
with a higher myocardial salvage index and may explain
the recently observed improved short time survival. Lar-
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